High throughput DNA sequencing for advanced genomic research
Illumina NovaSeq X Plus High Throughput DNA Sequencer for Emory University
This study is all about getting a new, high-tech DNA sequencing machine to help researchers at Emory University learn more about the genes involved in neurodegenerative diseases, which could lead to better treatments for patients like you in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11102640 on NIH RePORTER |
What this research studies
This research aims to enhance genomic analysis capabilities at Emory University by acquiring a state-of-the-art Illumina NovaSeq X Plus Sequencing System. The system will facilitate deep sequencing of DNA, allowing researchers to explore genome-wide DNA methylation profiles and identify differentially expressed genes, particularly in the context of neurodegenerative conditions. By providing in-house access to advanced sequencing technology, the project will support a diverse range of biomedical research initiatives and improve the efficiency and cost-effectiveness of genomic studies. Patients may benefit indirectly through advancements in understanding and treating neurodegenerative diseases.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals affected by neurodegenerative conditions or those involved in related biomedical research.
Not a fit: Patients with conditions unrelated to neurodegeneration or those not engaged in research activities may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to significant advancements in the understanding and treatment of neurodegenerative diseases.
How similar studies have performed: Previous research utilizing advanced sequencing technologies has shown significant success in enhancing our understanding of genetic factors in various diseases, indicating a promising potential for this approach.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Bosinger, Steven Edward — Emory University
- Study coordinator: Bosinger, Steven Edward
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.